Placebo matching BI 764198, BI 764198
1434-0027
Phase 2 small_molecule active
Quick answer
Placebo matching BI 764198, BI 764198 for Proteinuric kidney diseases is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Proteinuric kidney diseases
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active